Non-sugar sweeteners (NSS) should not be used, according to new UN health agency guidelines announced on Monday. The World Health Organisation (WHO) has issued a recommendation based on an assessment of the research that says artificial sweeteners do not assist regulate body mass or lower the risk of illnesses associated with obesity. Aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and various stevia derivatives are examples of common NSS. “Replacing free sugars with NSS does not help with weight control in the long term. People need to consider other ways to reduce free sugars intakes, such as consuming food with naturally occurring sugars, like fruit, or unsweetened food and beverages,” says Francesco Branca, WHO Director for Nutrition and Food Safety. “NSS are not essential dietary factors and have no nutritional value. People should reduce the sweetness of the diet altogether, starting early in life, to improve their health.”
The WHO’s advice does not apply to personal care and hygiene items like toothpaste, skin cream, and pharmaceuticals that contain non-sugar sweeteners
A higher risk of type 2 diabetes and cardiovascular disease were among the “potential undesirable effects from long-term use” of NSS that were mentioned by WHO. The review’s findings also imply that there might be other harmful effects, like a raised chance of adulthood-related early mortality. The recommendation against using NSS includes all artificial, naturally occurring, or modified non-nutritive sweeteners that are not classified as sugars and are present in manufactured foods and beverages or sold separately in addition to foods and beverages by consumers, with the exception of people who have pre-existing diabetes.
The WHO’s advice does not apply to personal care and hygiene items like toothpaste, skin cream, and pharmaceuticals that contain non-sugar sweeteners, as well as to low-calorie sugars and sugar alcohols (polyols), which are sugars or sugar derivatives with calories and are not considered NSS. Following WHO procedures for formulating guidelines, the advice has been “assessed as conditional” because the relationship between ingesting NSS and disease outcomes may be subjectively determined due to the “baseline characteristics” of persons participating in the study. This indicates that implementing policies based on the WHO recommendation may necessitate extensive discussion in certain settings, such as those related to the extent of consumption in various age groups across different nations.
